BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Smith AG, Singleton JR. The diagnostic yield of a standardized approach to idiopathic sensory-predominant neuropathy. Arch Intern Med. 2004;164:1021-1025. [PMID: 15136313 DOI: 10.1001/archinte.164.9.1021] [Cited by in Crossref: 65] [Cited by in F6Publishing: 70] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Currò R, Salvalaggio A, Tozza S, Gemelli C, Dominik N, Galassi Deforie V, Magrinelli F, Castellani F, Vegezzi E, Businaro P, Callegari I, Pichiecchio A, Cosentino G, Alfonsi E, Marchioni E, Colnaghi S, Gana S, Valente EM, Tassorelli C, Efthymiou S, Facchini S, Carr A, Laura M, Rossor AM, Manji H, Lunn MP, Pegoraro E, Santoro L, Grandis M, Bellone E, Beauchamp NJ, Hadjivassiliou M, Kaski D, Bronstein AM, Houlden H, Reilly MM, Mandich P, Schenone A, Manganelli F, Briani C, Cortese A. RFC1 expansions are a common cause of idiopathic sensory neuropathy. Brain 2021;144:1542-50. [PMID: 33969391 DOI: 10.1093/brain/awab072] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 23.0] [Reference Citation Analysis]
2 Samuelsson K, Press R. Chronic axonal idiopathic polyneuropathy: is it really benign. Curr Opin Neurol 2020;33:562-7. [PMID: 32773448 DOI: 10.1097/WCO.0000000000000847] [Reference Citation Analysis]
3 Zilliox LA. Diabetes and Peripheral Nerve Disease. Clin Geriatr Med 2021;37:253-67. [PMID: 33858608 DOI: 10.1016/j.cger.2020.12.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Zis P, Sarrigiannis PG, Artemiadis A, Skarlatou V, Hadjivassiliou M. Chronic idiopathic axonal polyneuropathy: Electrophysiological progression and human leukocyte antigen associations. Muscle Nerve 2021;63:567-71. [PMID: 33440030 DOI: 10.1002/mus.27164] [Reference Citation Analysis]
5 Callaghan BC. Test Utilization and Value in the Evaluation of Peripheral Neuropathies. Continuum (Minneap Minn) 2020;26:1384-91. [PMID: 33003007 DOI: 10.1212/CON.0000000000000910] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Burakgazi AZ. Efficacy of Electrical Stimulation on Nerve Fiber Growth in Small Fiber Neuropathy. J Clin Neuromuscul Dis 2020;21:187-94. [PMID: 32453094 DOI: 10.1097/CND.0000000000000280] [Reference Citation Analysis]
7 Horlings CGC, Rath J, Finsterer J, Wanschitz JV, Löscher WN. Laboratory Tests for Neuropathies: What to do and to Avoid. J Neuromuscul Dis 2020;7:279-86. [PMID: 32333547 DOI: 10.3233/JND-200488] [Reference Citation Analysis]
8 Karagöz T, Bayir Ö, Çadalli Tatar E, Çakal E, Özdek A, Keseroğlu K, Şahin M, Korkmaz MH. Prognostic role of homeostasis model assessment and oral glucose tolerance test in nondiabetic patients with Bell’s palsy. Turk J Med Sci 2020;50:405-10. [PMID: 32041386 DOI: 10.3906/sag-1901-151] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Mahat RK, Singh N, Arora M, Rathore V. Health risks and interventions in prediabetes: A review. Diabetes Metab Syndr 2019;13:2803-11. [PMID: 31405710 DOI: 10.1016/j.dsx.2019.07.041] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
10 Zis P, McHugh PC, Manca M, Sarrigiannis PG, Rao DG, Hadjivassiliou M. Increased Oxidative Stress as a Risk Factor in Chronic Idiopathic Axonal Polyneuropathy. J Mol Neurosci 2018;66:547-51. [PMID: 30350254 DOI: 10.1007/s12031-018-1200-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
11 Sabatelli M, Laurenti L, Luigetti M. Peripheral Nervous System Involvement in Lymphoproliferative Disorders. Mediterr J Hematol Infect Dis 2018;10:e2018057. [PMID: 30210750 DOI: 10.4084/MJHID.2018.057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Doughty CT, Seyedsadjadi R. Approach to Peripheral Neuropathy for the Primary Care Clinician. The American Journal of Medicine 2018;131:1010-6. [DOI: 10.1016/j.amjmed.2017.12.042] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
13 Gwathmey KG. Sensory Polyneuropathies. Continuum (Minneap Minn) 2017;23:1411-36. [PMID: 28968369 DOI: 10.1212/CON.0000000000000518] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
14 Sun B, Liu LZ, Li YF, Chen ZH, Ling L, Yang F, Cui F, Huang XS. Clinical Characteristics, Electrophysiology, and Skin Biopsy of 38 Peripheral Neuropathy Cases with Small Fiber Involvement of Various Etiologies. Chin Med J (Engl) 2017;130:1683-8. [PMID: 28685718 DOI: 10.4103/0366-6999.209897] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
15 Samuelsson K, Press R. Microangiopathy-A Potential Contributing Factor to Idiopathic Polyneuropathy: A Mini Review. Front Neurol 2018;9:43. [PMID: 29483890 DOI: 10.3389/fneur.2018.00043] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
16 Sun B, Li Y, Liu L, Chen Z, Ling L, Yang F, Liu J, Liu H, Huang X. SFN-SIQ, SFNSL and skin biopsy of 55 cases with small fibre involvement. Int J Neurosci 2018;128:442-8. [PMID: 29077516 DOI: 10.1080/00207454.2017.1398152] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
17 Nienov OH, Matte L, Dias LS, Schmid H. Peripheral polyneuropathy in severely obese patients with metabolic syndrome but without diabetes: Association with low HDL-cholesterol. Rev Assoc Med Bras 2017;63:324-31. [DOI: 10.1590/1806-9282.63.04.324] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
18 Hube L, Dohrn MF, Karsai G, Hirshman S, Van Damme P, Schulz JB, Weis J, Hornemann T, Claeys KG. Metabolic Syndrome, Neurotoxic 1-Deoxysphingolipids and Nervous Tissue Inflammation in Chronic Idiopathic Axonal Polyneuropathy (CIAP). PLoS One 2017;12:e0170583. [PMID: 28114358 DOI: 10.1371/journal.pone.0170583] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
19 Lang M, Treister R, Oaklander AL. Diagnostic value of blood tests for occult causes of initially idiopathic small-fiber polyneuropathy. J Neurol 2016;263:2515-27. [PMID: 27730378 DOI: 10.1007/s00415-016-8270-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
20 Samuelsson K, Osman AA, Angeria M, Risling M, Mohseni S, Press R. Study of Autophagy and Microangiopathy in Sural Nerves of Patients with Chronic Idiopathic Axonal Polyneuropathy. PLoS One 2016;11:e0163427. [PMID: 27662650 DOI: 10.1371/journal.pone.0163427] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
21 Juster-Switlyk K, Smith AG. Updates in diabetic peripheral neuropathy. F1000Res 2016;5:F1000 Faculty Rev-738. [PMID: 27158461 DOI: 10.12688/f1000research.7898.1] [Cited by in Crossref: 142] [Cited by in F6Publishing: 147] [Article Influence: 23.7] [Reference Citation Analysis]
22 Wang W, Wang C, Dawson DB, Thorland EC, Lundquist PA, Eckloff BW, Wu Y, Baheti S, Evans JM, Scherer SS, Dyck PJ, Klein CJ. Target-enrichment sequencing and copy number evaluation in inherited polyneuropathy. Neurology 2016;86:1762-71. [PMID: 27164712 DOI: 10.1212/WNL.0000000000002659] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 6.8] [Reference Citation Analysis]
23 Zis P, Sarrigiannis PG, Rao DG, Hewamadduma C, Hadjivassiliou M. Chronic idiopathic axonal polyneuropathy: a systematic review. J Neurol 2016;263:1903-10. [DOI: 10.1007/s00415-016-8082-7] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 8.8] [Reference Citation Analysis]
24 Farhad K, Traub R, Ruzhansky KM, Brannagan TH. Causes of neuropathy in patients referred as “idiopathic neuropathy”: Causes of Neuropathy. Muscle Nerve 2016;53:856-61. [DOI: 10.1002/mus.24969] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 7.9] [Reference Citation Analysis]
25 Callaghan BC, Price RS, Feldman EL. Distal Symmetric Polyneuropathy: A Review. JAMA 2015;314:2172-81. [PMID: 26599185 DOI: 10.1001/jama.2015.13611] [Cited by in Crossref: 130] [Cited by in F6Publishing: 138] [Article Influence: 18.6] [Reference Citation Analysis]
26 Watson JC, Dyck PJB. Peripheral Neuropathy: A Practical Approach to Diagnosis and Symptom Management. Mayo Clinic Proceedings 2015;90:940-51. [DOI: 10.1016/j.mayocp.2015.05.004] [Cited by in Crossref: 108] [Cited by in F6Publishing: 117] [Article Influence: 15.4] [Reference Citation Analysis]
27 Azam M, Marwood L, Ismail K, Evans T, Sivaprasad S, Winkley K, Amiel SA. Diabetes Complications at Presentation and One Year by Glycated Haemoglobin at Diagnosis in a Multiethnic and Diverse Socioeconomic Population: Results from the South London Diabetes Study. J Diabetes Res 2015;2015:587673. [PMID: 26090473 DOI: 10.1155/2015/587673] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
28 Klein SE, Chu J, Mccormick JJ, Johnson JE. Evaluation of Peripheral Neuropathy of Unknown Origin in an Outpatient Foot and Ankle Practice. Foot Ankle Int 2015;36:1058-63. [DOI: 10.1177/1071100715583352] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
29 Bansal N. Prediabetes diagnosis and treatment: A review. World J Diabetes 2015; 6(2): 296-303 [PMID: 25789110 DOI: 10.4239/wjd.v6.i2.296] [Cited by in CrossRef: 243] [Cited by in F6Publishing: 256] [Article Influence: 34.7] [Reference Citation Analysis]
30 Ince H, Taşdemir HA, Aydin M, Ozyürek H, Tilki HE. Evaluation of Nerve Conduction Studies in Obese Children With Insulin Resistance or Impaired Glucose Tolerance. J Child Neurol 2015;30:989-99. [DOI: 10.1177/0883073814550188] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
31 Doppler K, Sommer C, Reiners K. Identifizierung neuropathischer Defizite und Schädigungstypen. NeuroTransmitter 2014;25:66-78. [DOI: 10.1007/s15016-014-0003-3] [Reference Citation Analysis]
32 Ziegler D, Papanas N, Vinik AI, Shaw JE. Epidemiology of polyneuropathy in diabetes and prediabetes. Diabetes and the Nervous System. Elsevier; 2014. pp. 3-22. [DOI: 10.1016/b978-0-444-53480-4.00001-1] [Cited by in Crossref: 125] [Cited by in F6Publishing: 130] [Article Influence: 15.6] [Reference Citation Analysis]
33 Zhou L. Skin Biopsy. Neuromuscular Disorders in Clinical Practice 2014. [DOI: 10.1007/978-1-4614-6567-6_13] [Reference Citation Analysis]
34 Cortez M, Singleton JR, Smith AG. Glucose intolerance, metabolic syndrome, and neuropathy. Diabetes and the Nervous System. Elsevier; 2014. pp. 109-22. [DOI: 10.1016/b978-0-444-53480-4.00009-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
35 Pratley RE. The early treatment of type 2 diabetes. Am J Med 2013;126:S2-9. [PMID: 23953075 DOI: 10.1016/j.amjmed.2013.06.007] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
36 Gallagher G, Rabquer A, Kerber K, Calabek B, Callaghan B. Value of thyroid and rheumatologic studies in the evaluation of peripheral neuropathy. Neurol Clin Pract 2013;3:90-8. [PMID: 23914318 DOI: 10.1212/CPJ.0b013e31828d9f2c] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
37 김동휘, 김창환, 김우경, 권희규, 권기한. An Evidence-Based Electrodignositc Guidelines for the Diagnosis of Diabetic Sensory and Motor Polyneuropathy. jouranlofkoreanassociationofemgelectrodiagnosticmedicine 2012;14:47-54. [DOI: 10.18214/jkaem.2012.14.2.47] [Reference Citation Analysis]
38 Callaghan B, Kerber K, Longoria R, Feldman E, Lisabeth L. Capturing cases of distal symmetric polyneuropathy in a community. Muscle Nerve 2012;46:943-7. [PMID: 23042289 DOI: 10.1002/mus.23449] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
39 Smith AG, Singleton JR. Diabetic neuropathy. Continuum (Minneap Minn) 2012;18:60-84. [PMID: 22810070 DOI: 10.1212/01.CON.0000411568.34085.3e] [Cited by in Crossref: 23] [Cited by in F6Publishing: 41] [Article Influence: 2.3] [Reference Citation Analysis]
40 Smith AG. Impaired glucose tolerance and metabolic syndrome in idiopathic neuropathy. J Peripher Nerv Syst 2012;17 Suppl 2:15-21. [PMID: 22548618 DOI: 10.1111/j.1529-8027.2012.00390.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
41 Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes: a high-risk state for diabetes development. Lancet. 2012;379:2279-2290. [PMID: 22683128 DOI: 10.1016/s0140-6736(12)60283-9] [Cited by in Crossref: 1388] [Cited by in F6Publishing: 1478] [Article Influence: 138.8] [Reference Citation Analysis]
42 Papanas N, Ziegler D. Prediabetic Neuropathy: Does It Exist? Curr Diab Rep 2012;12:376-83. [DOI: 10.1007/s11892-012-0278-3] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 4.2] [Reference Citation Analysis]
43 Callaghan B, McCammon R, Kerber K, Xu X, Langa KM, Feldman E. Tests and expenditures in the initial evaluation of peripheral neuropathy. Arch Intern Med 2012;172:127-32. [PMID: 22271119 DOI: 10.1001/archinternmed.2011.1032] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
44 Cheng J, Daftari A, Zhou L. Sympathetic blocks provided sustained pain relief in a patient with refractory painful diabetic neuropathy. Case Rep Anesthesiol 2012;2012:285328. [PMID: 22606406 DOI: 10.1155/2012/285328] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
45 Crum BA, Rubin DI, Dimberg EL, Goodman BP. Neuromuscular Disorders. Neurology 2012. [DOI: 10.1007/978-0-387-88555-1_9] [Reference Citation Analysis]
46 Kim TS, Cho WK, Cho KS, Park SH, Hahn SH, Jung MH, Suh BK. A Case of Type 2 Diabetes Mellitus in Adolescent Presenting with Bell's Palsy. Ann Pediatr Endocrinol Metab 2012;17:258. [DOI: 10.6065/apem.2012.17.4.258] [Reference Citation Analysis]
47 Vinik AI, Nevoret M. Neuropathy in Prediabetes and the Metabolic Syndrome. Prevention of Type 2 Diabetes 2012. [DOI: 10.1007/978-1-4614-3314-9_8] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
48 Leishear K, Ferrucci L, Lauretani F, Boudreau RM, Studenski SA, Rosano C, Abbate R, Gori AM, Corsi AM, Di Iorio A, Guralnik JM, Bandinelli S, Newman AB, Strotmeyer ES. Vitamin B12 and homocysteine levels and 6-year change in peripheral nerve function and neurological signs. J Gerontol A Biol Sci Med Sci 2012;67:537-43. [PMID: 22156506 DOI: 10.1093/gerona/glr202] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
49 Papanas N, Vinik AI, Ziegler D. Neuropathy in prediabetes: does the clock start ticking early? Nat Rev Endocrinol. 2011;7:682-690. [PMID: 21750507 DOI: 10.1038/nrendo.2011.113] [Cited by in Crossref: 142] [Cited by in F6Publishing: 148] [Article Influence: 12.9] [Reference Citation Analysis]
50 Zhou L, Li J, Ontaneda D, Sperling J. Metabolic Syndrome in Small Fiber Sensory Neuropathy. Journal of Clinical Neuromuscular Disease 2011;12:235-43. [DOI: 10.1097/cnd.0b013e3182196e3c] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
51 Bosco D, Plastino M, Bosco F, Consoli A, Labate A, Pirritano D, Consoli D, Fava A. Bell's palsy: a manifestation of prediabetes? Acta Neurol Scand 2011;123:68-72. [PMID: 20545630 DOI: 10.1111/j.1600-0404.2010.01365.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
52 Hsueh WA, Orloski L, Wyne K. Prediabetes: the importance of early identification and intervention. Postgrad Med 2010;122:129-43. [PMID: 20675976 DOI: 10.3810/pgm.2010.07.2180] [Cited by in Crossref: 27] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
53 Gdynia HJ, Ludolph AC. Polyneuropathy in type 1 and type 2 diabetes: do we need different examinations? Diabetes Metab Res Rev 2010;26:107-8. [PMID: 20355003 DOI: 10.1002/dmrr.1067] [Reference Citation Analysis]
54 Bosco D, Costa R, Plastino M, Branca D, Cotronei P, Sperlì T, Santacroce N, Siniscalchi A, Consoli D, Ceccotti C, Mungari P, Fava A. Glucose metabolism in the idiopathic blepharoptosis: Utility of the Oral Glucose Tolerance Test (OGTT) and of the Insulin Resistance Index. Journal of the Neurological Sciences 2009;284:24-8. [DOI: 10.1016/j.jns.2009.03.017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
55 Douglass C, Mcdermott CJ. Assessment and Diagnosis of Sensory Disturbance. InnovAiT 2009;2:531-537. [DOI: 10.1093/innovait/inp099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
56 Greenberg BM. The Neurologic Manifestations of Systemic Lupus Erythematosus. The Neurologist 2009;15:115-21. [DOI: 10.1097/nrl.0b013e31818ff9aa] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
57 England JD, Gronseth GS, Franklin G, Carter GT, Kinsella LJ, Cohen JA, Asbury AK, Szigeti K, Lupski JR, Latov N, Lewis RA, Low PA, Fisher MA, Herrmann D, Howard JF, Lauria G, Miller RG, Polydefkis M, Sumner AJ; American Academy of Neurology., American Association of Neuromuscular and Electrodiagnostic Medicine., American Academy of Physical Medicine and Rehabilitation. Evaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing (an evidence-based review). Muscle Nerve 2009;39:116-25. [PMID: 19086068 DOI: 10.1002/mus.21226] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 3.8] [Reference Citation Analysis]
58 Singleton JR, Bixby B, Russell JW, Feldman EL, Peltier A, Goldstein J, Howard J, Smith AG. The Utah Early Neuropathy Scale: a sensitive clinical scale for early sensory predominant neuropathy. J Peripher Nerv Syst. 2008;13:218-227. [PMID: 18844788 DOI: 10.1111/j.1529-8027.2008.00180.x] [Cited by in Crossref: 149] [Cited by in F6Publishing: 156] [Article Influence: 11.5] [Reference Citation Analysis]
59 Nebuchennykh M, Løseth S, Jorde R, Mellgren SI. Idiopathic polyneuropathy and impaired glucose metabolism in a Norwegian patient series. Eur J Neurol. 2008;15:810-816. [PMID: 18549398 DOI: 10.1111/j.1468-1331.2008.02197.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 2.6] [Reference Citation Analysis]
60 Smith AG, Singleton JR. Impaired glucose tolerance and neuropathy. Neurologist 2008;14:23-9. [PMID: 18195653 DOI: 10.1097/NRL.0b013e31815a3956] [Cited by in Crossref: 109] [Cited by in F6Publishing: 109] [Article Influence: 7.8] [Reference Citation Analysis]
61 Singleton JR, Smith AG. Neuropathy associated with prediabetes: what is new in 2007? Curr Diab Rep 2007;7:420-4. [PMID: 18255003 DOI: 10.1007/s11892-007-0070-y] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
62 Singleton JR, Smith AG. Therapy insight: neurological complications of prediabetes. Nat Clin Pract Neurol 2006;2:276-82. [PMID: 16932564 DOI: 10.1038/ncpneuro0172] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
63 Chan TY. A Probable Case of Amygdalin-Induced Peripheral Neuropathy in a Vegetarian With Vitamin B12 Deficiency. Therapeutic Drug Monitoring 2006;28:140-1. [DOI: 10.1097/01.ftd.0000179419.40584.15] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
64 Gordon Smith A, Robinson Singleton J. Idiopathic neuropathy, prediabetes and the metabolic syndrome. J Neurol Sci 2006;242:9-14. [PMID: 16448668 DOI: 10.1016/j.jns.2005.11.020] [Cited by in Crossref: 89] [Cited by in F6Publishing: 94] [Article Influence: 5.6] [Reference Citation Analysis]
65 Benatar M. Polyneuropathy. Neuromuscular Disease 2006. [DOI: 10.1007/978-1-59745-106-2_8] [Reference Citation Analysis]
66 Diagnostic Yield for Peripheral Neuropathy. Neurological Disease and Therapy 2005. [DOI: 10.1201/b14157-46] [Reference Citation Analysis]
67 What's in the Literature? Journal of Clinical Neuromuscular Disease 2005;6:136-143. [DOI: 10.1097/01.cnd.0000156266.83921.3a] [Reference Citation Analysis]
68 Singleton JR, Smith AG, Russell J, Feldman EL. Polyneuropathy with Impaired Glucose Tolerance: Implications for Diagnosis and Therapy. Curr Treat Options Neurol. 2005;7:33-42. [PMID: 15610705 DOI: 10.1007/s11940-005-0004-4] [Cited by in Crossref: 43] [Cited by in F6Publishing: 49] [Article Influence: 2.5] [Reference Citation Analysis]